Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Centessa Pharmaceuticals plc
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee |
Carry Type |
Carry Forward File Number |
Carry Forward Initial effective date |
Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||
| Fees to Be Paid | Equity | Ordinary shares, nominal value £0.002 per share (3) | 457(r) (2) | (1) | (1) | (1) | (2) | (2) | ||||||||||||||||
| Debt | Senior Debt Securities | 457(r) (2) | (1) | (1) | (1) | (2) | (2) | |||||||||||||||||
| Debt | Subordinated Debt Securities | 457(r) (2) | (1) | (1) | (1) | (2) | (2) | |||||||||||||||||
| Other | Warrants | 457(r) (2) | (1) | (1) | (1) | (2) | (2) | |||||||||||||||||
| Other | Units | 457(r) (2) | (1) | (1) | (1) | (2) | (2) | |||||||||||||||||
| Fees Previously Paid |
— | — | — | — | — | — | — | |||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||
| Carry Forward Securities |
— | — | — | — | — | — | — | — | — | |||||||||||||||
| Total Offering Amounts | (1) | (1) | ||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | (2) | |||||||||||||||||||||||
| (1) | An indeterminate number of or aggregate principal amount of the securities of each identified class is being registered, as may at various times be issued at indeterminate prices. Any securities registered hereunder may be sold separately or together with other securities registered hereunder. |
| (2) | In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant is deferring payment of all of the registration fee. Any registration fees will be paid subsequently on a pay-as-you-go basis in accordance with Rule 456(b). |
| (3) | In addition to any securities that may be registered hereunder, we are also registering an indeterminate number of ordinary shares as may be issued upon conversion or exercise of the securities issued directly hereunder. No separate consideration will be received for any ordinary shares so issued upon conversion or exercise. The ordinary shares may be represented by American depositary shares (the “Ordinary ADSs”), each of which represents a specified number of ordinary shares. Ordinary ADSs issuable upon deposit of the ordinary shares registered hereby have been or will be registered under a separate registration statement on Form F-6. |